Non-Hodgkin lymphoma response evaluation with MRI texture classification.
Lara C V Harrison1, Tiina Luukkaala, Hannu Pertovaara
1Tampere University Medical School, Tampere, Finland. lara.harrison@tut.fi
Journal of Experimental & Clinical Cancer Research : CR
|June 24, 2009
Summary
Magnetic resonance imaging (MRI) texture analysis can quantify non-Hodgkin lymphoma (NHL) changes during chemotherapy. This method shows potential for monitoring treatment response in lymphoma patients.
Area of Science:
- Radiology
- Oncology
- Medical Imaging Analysis
Background:
- Non-Hodgkin lymphoma (NHL) treatment response evaluation is critical.
- Quantitative methods are needed to objectively assess treatment efficacy.
- Magnetic resonance imaging (MRI) offers detailed tissue visualization.
Purpose of the Study:
- To investigate changes in MRI texture appearance during NHL treatment.
- To evaluate the role of quantitative volume analysis in monitoring treatment response.
- To establish MRI texture analysis as a tool for assessing chemotherapy effectiveness in lymphoma.
Main Methods:
- 19 patients with evaluable NHL lesions were included.
- Three MRI timepoints were acquired using a 1.5T device during treatment.
- Texture characteristics were analyzed using MaZda software and statistical tests.
Main Results:
- NHL tissue MRI texture was classified into subgroups before and during chemotherapy.
- Non-linear discriminant analysis of T2-weighted images achieved 96% correct classification.
- Statistical tests confirmed the impact of texture parameters in evaluating chemotherapy response.
Conclusions:
- MRI texture characteristics were successfully classified.
- Texture analysis demonstrates potential as a quantitative method for monitoring lymphoma tissue changes during chemotherapy.
- This approach can aid in assessing treatment response in NHL.
